North Bristol data is the largest to move

The migration of data to North Bristol NHS Trust’s new VNA was Insignia’s largest and fastest migration to date, moving 300TB of medical imaging across to the new VNA. Data was processed at a rate of 11-12 million images a day and was completed in just five months. With COVID-19 impacting healthcare services, Insignia and the trust worked together to deploy hardware and performed the RIS data import, completing the work at the end of August.

The trust selected Insignia for five key components: Wellbeing CRIS for the RIS; Insignia Medical Systems PACS; Insignia Medical Systems VNA; TeraRecon for Advanced Image Processing; and Voice Recognition from Wellbeing. Go-live was expected to take place in March, in line with the end of the existing contracts.

Trust PACS manager Sue Miller said: “Deploying a new PACS is always challenging and exciting. The success of this implementation is reliant upon good support and partnership with trust stakeholders and the supplier, and the achievement to date in all aspects demonstrates this very well.”

The trust site has more than 220 modality connections and a daily study-performed rate of around 1,600 studies. Insignia will be deploying its zero footprint viewer, giving users fast, flexible and secure access to patient images and information across multiple platforms and displays, along with regional sharing solutions that enable examinations to be viewed and reported anywhere in a region.

Clinical lead for imaging and consultant neuroradiologist Dr Marcus Bradley added: “The project team from Insignia has demonstrated a very calm and professional approach, overcoming all obstacles thrown at them by the pandemic, to ensure a smooth installation process. We are very much looking forward to being able to use the live product in the next few weeks.”

Picture: Southmead Hospital

Published on page 16 of the April 2021 issue of RAD Magazine.

 

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more